Amylyx Pharmaceuticals, Inc. ( AMLX ) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDT

Company Participants

Lindsey Allen - Head of Investor Relations & Communications

Justin Klee - Co-Founder, Co-CEO & Director

Dan Monahan - Chief Commercial Officer

Camille Bedrosian - Chief Medical Officer

James Frates - Chief Financial Officer

Joshua Cohen - Co-Founder, Co-CEO & Director

Conference Call Participants

Seamus Fernandez - Guggenheim Securities, LLC, Research Division

Kevin Strang - Goldman Sachs Group, Inc., Research Division

Michael DiFiore - Evercore ISI Institutional Equities, Research Division

Marc Goodman - Leerink Partners LLC, Research Division

Geoffrey Meacham - Citigroup Inc., Research Division

Rami Katkhuda - LifeSci Capital, LLC, Research Division

Samuel Lee - Mizuho Securities USA LLC, Research Division

Christopher Chen - Robert W. Baird & Co. Incorporated, Research Division

Ananda Ghosh - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Good morning.…